Arete Wealth Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,843	Closed	-$277K	–	599
2025 Q4	$277K	Buy	30,843 +15,675	+103%	+$216K	0.02%	620
2025 Q3	$262K	Hold	15,168	–	–	0.02%	642
2025 Q2	$142K	Buy	15,168 +2,656	+21%	+$21.8K	0.01%	699
2025 Q1	$89K	Buy	12,512 +2,240	+22%	+$22.6K	0.01%	694
2024 Q4	$121K	Buy	+10,272	New	+$160K	0.01%	719
2024 Q1	–	Sell	-7,220	Closed	-$220K	–	616
2023 Q4	$220K	Buy	7,220 +182	+3%	+$5.23K	0.02%	647
2023 Q3	$223K	Buy	+7,038	New	+$273K	0.04%	410
2022 Q2	–	Sell	-2,874	Closed	-$209K	–	527
2022 Q1	$209K	Sell	2,874 -73	-2%	-$6.18K	0.02%	470
2021 Q4	$348K	Buy	+2,947	New	+$369K	0.03%	358